Status:
RECRUITING
Non-Helium Magnetoencephalography in Pediatric Brain Tumors
Lead Sponsor:
Guangzhou Women and Children's Medical Center
Collaborating Sponsors:
Beijing X-Magtech Technology Limited
Conditions:
Pediatric Brain Tumor
Eligibility:
All Genders
3-18 years
Brief Summary
This observational study aims to evaluate the effectiveness of magnetoencephalography (MEG) in the preoperative assessment of pediatric brain tumors, particularly in determining the extent of resectio...
Eligibility Criteria
Inclusion
- Age range: 3-18 years old;
- Clinically diagnosed with brain tumor;
- Capable of cooperating with magnetoencephalography evaluation and recording.
Exclusion
- Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination.
- Patients using drugs that affect central nervous system function;
- Patients who are not suitable for surgical procedures;
- Patients with progressive neurological disorders.
Key Trial Info
Start Date :
November 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06943742
Start Date
November 5 2024
End Date
December 31 2027
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Women and Children's medical center
Guangzhou, Guangdong, China, 511399